Ardent Health (NYSE:ARDT) Given New $12.00 Price Target at Truist Financial

Ardent Health (NYSE:ARDT) had its price objective cut by equities research analysts at Truist Financial from $13.00 to $12.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s target price indicates a potential upside of 25.79% from the company’s current price.

Other research analysts have also issued research reports about the company. Royal Bank Of Canada decreased their price objective on Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, July 9th. Wall Street Zen cut shares of Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th. UBS Group boosted their price target on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Ardent Health currently has an average rating of “Hold” and an average price target of $14.04.

Ardent Health Trading Down 5.3%

ARDT stock opened at $9.54 on Tuesday. Ardent Health has a 12-month low of $7.71 and a 12-month high of $15.48. The business’s 50-day moving average is $9.61 and its 200 day moving average is $9.27. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. The stock has a market cap of $1.37 billion, a price-to-earnings ratio of 9.99, a PEG ratio of 2.29 and a beta of 0.76.

Ardent Health (NYSE:ARDT) last announced its earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.10. The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, sell-side analysts anticipate that Ardent Health will post 1.1 EPS for the current fiscal year.

Insider Activity

In related news, CFO Alfred Lumsdaine bought 10,000 shares of the business’s stock in a transaction on Friday, June 5th. The stock was acquired at an average cost of $8.81 per share, with a total value of $88,100.00. Following the purchase, the chief financial officer directly owned 329,183 shares of the company’s stock, valued at $2,900,102.23. The trade was a 3.13% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.90% of the stock is owned by company insiders.

Institutional Investors Weigh In On Ardent Health

A number of hedge funds have recently modified their holdings of ARDT. Goldentree Asset Management LP raised its stake in Ardent Health by 99.7% during the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after purchasing an additional 1,150,000 shares during the period. Ameriprise Financial Inc. increased its holdings in shares of Ardent Health by 8.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,769,335 shares of the company’s stock worth $23,444,000 after buying an additional 134,513 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Ardent Health by 44.5% during the 3rd quarter. Vanguard Group Inc. now owns 1,352,676 shares of the company’s stock worth $17,923,000 after buying an additional 416,348 shares during the last quarter. Millennium Management LLC raised its position in shares of Ardent Health by 6.6% during the 3rd quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock valued at $16,822,000 after buying an additional 78,861 shares during the period. Finally, Bridgeway Capital Management LLC raised its position in shares of Ardent Health by 108.2% during the 4th quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock valued at $8,358,000 after buying an additional 491,961 shares during the period.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.